MIRA INFORM REPORT

 

 

Report Date :

22.02.2014

 

IDENTIFICATION DETAILS

 

Name :

FARMOQUIMICA S/A

 

 

Registered Office :

Av. José Silva De Azevedo Neto,200 Andar 1, Bloco 1, Salas 101,102,103,104,106, 107, - Barra Da Tijuca, 22775-056 - Rio De Janeiro/Rj

 

 

Country :

 Brazil

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

06.05.1946

 

 

Legal Form :

Privately Held Corporation

 

 

Line of Business :

Manufacturer of pharmaceuticals

 

 

No of Employees :

817

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1.000.000,00

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – december 01, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% in 2011, and 1.3% in 2012. Unemployment is at historic lows and Brazil's traditionally high level of income inequality has declined for each of the last 14 years. Brazil's historically high interest rates have made it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchange markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint. In an effort to boost growth, in 2012 the administration implemented a somewhat more expansionary monetary policy that has failed to stimulate much growth.

 

Source : CIA

 


 

COMPANY NAME

 

FARMOQUIMÍCA S/A

 

 

ADDRESSES

 

MAIN ADDRESS:

AV. JOSÉ SILVA DE AZEVEDO NETO,200 ANDAR 1, BLOCO 1, SALAS 101,102,103,104,106, 107, - BARRA DA TIJUCA

ZIP CODE/CITY:

22775-056 - RIO DE JANEIRO/RJ

 

 

PHONE:

21 2122-6100

FAX:

21 2104-9527

E-MAIL:

rcaetano@fqm.com.br

WEB SITE:

www.farmoquimica.com.br

 

BRANCHES:

 

 

 

ADDRESS:

RUA ARSENAL,1635

ZIP CODE/CITY:

SÃO GONÇALO/RJ

 

 

ADDRESS:

RUA VIÚVA CLÁUDIO,300 - JACARÉ

ZIP CODE/CITY:

20970-030 RIO DE JANEIRO/RJ

PHONE:

21 2122-6000

CNPJ:

333494730

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS

 

 

LEGAL FORM:

PRIVATELY HELD CORPORATION

 

 

INCORPORATION DATE:

06/05/1946

REGISTER DATE:

06/05/1946

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

33.349.473/0001-58

STATE REGISTER:

81.395.640

 

 

SHARE CAPITAL:

R$ 49.367.748,00

 

BOARD OF DIRECTORS:

 

 

 

MARCELO GERALDI

PRESIDENT DIRECTOR

FERNANDO GABRIEL ITZAIMA SANCHEZ

VICE-PRESIDENT DIRECTOR

 

 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

SILMORE COMPANY SOCIEDAD ANONIMA (URUGUAY)

53,5%

OTHERS

33,3%

ELOISIO CRUZ GERALDI

6,6%

MARCELO GERALDI

6,6%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

IODOS ADMINISTRAÇÃO DE BENS LTDA

99,9%

HERBARIUM LABORATORIO BOTANICO LTDA

100%

TIME STOCK COM E REPRESENTAÇÕES LTDA

43,2%

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON MAY 6, 1946 TO BE ENGAGED IN THE SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN. THE COMPANY OPERATES WITH THE TRADE NAME FQM.

 

IN JULY 2007 THE COMPANY TOOK OVER TRAVERSE PARTICIPAÇÕES LTDA, CNPJ 08.380.611-14.

 

CERTIFICATIONS:

**************

 

ISO 9002:1994,

NBR ISO 9001:2000

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2012

31/12/2011

31/12/2010

 

 

 

 

CASH AND CASH EQUIVALENTS

4.344

2.790

10.840

CLIENTS

57.552

52.637

35.475

INVENTORY

31.849

28.228

24.732

RECOVERABLE TAXES

8.816

995

497

CREDIT WITH RELATED PARTIES

 

39.568

13.664

PRE PAID EXPENSES

 

171

473

OTHER CREDITS

4.515

2.673

2.230

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

107.076

127.062

87.911

 

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

INTERCOMPANY CREDITS

18.783

5.259

7.149

INVENTORY

 

1.000

5.112

DEFERRED TAXES

2.330

1.422

4.012

JUDICIAL DEPOSITS

5.401

4.986

4.354

PRE PAID EXPENSES

2.732

 

 

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

29.246

12.667

20.627

 

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

23.483

4.704

2.899

FIXED ASSETS

42.949

41.086

33.110

INTANGIBLE

86.272

74.133

3.546

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

152.704

119.923

39.555

 

================

================

=============

TOTAL ASSETS

289.026

259.652

148.093

 

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2012

31/12/2011

31/12/2010

 

 

 

 

SUPPLIERS

17.190

11.066

11.028

SOCIAL OBLIGATIONS

13.960

10.620

7.291

TAXES & CONTRIBUTIONS

9.048

8.311

6.336

ACCOUNTS PAYABLE

4.984

4.870

 

LOANS AND FINANCING

30.049

27.824

512

DIVIDENDS

9.984

39.144

13.289

OTHER

281

1.062

547

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

85.496

102.897

39.003

 

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

14.102

1.585

2.053

ACCOUNTS PAYABLE

52.930

49.352

 

PROVISION FOR CONTINGENCIES

7.048

7.374

7.375

OTHER

 

200

399

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

74.080

58.511

9.827

 

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

49.368

49.368

49.368

CAPITAL RESERVES

7.307

7.307

7.307

PROFIT RESERVES

72.775

41.569

42.532

DIVIDENDS

 

 

56

 

----------------

----------------

----------------

TOTAL NET EQUITY

129.450

98.244

99.263

 

================

================

=============

TOTAL LIABILITIES

289.026

259.652

148.093

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

 

 

31/12/2012

31/12/2011

31/12/2010

 

 

 

 

NET SALES

360.784

284.761

235.947

(-) COST OF SOLD GOODS

94.399

72.581

61.297

 

----------------

----------------

----------------

GROSS PROFIT

266.385

212.180

174.650

OPERATING REVENUE (EXPENSE)

-190.251

-169.247

-131.236

FINANCIAL REVENUE(EXPENSE)

-14.251

-258

2.473

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

61.883

42.675

45.887

CONTRIBUTION/INCOME TAX

-19.845

-16.945

-15.330

 

----------------

----------------

----------------

NET PROFIT (LOSS)

42.038

25.730

30.557

 

 

RATIOS:

31/12/2012

31/12/2011

31/12/2010

 

QUICK RATIO

,88

 

,96

 

1,62

 

CURRENT RATIO

1,25

 

1,23

 

2,25

 

ACCOUNTS RECEIVABLE TURNOVER

6,27

TIMES

5,41

TIMES

6,65

TIMES

DAYS' SALES IN RECEIVABLES

57,43

DAYS

66,54

DAYS

54,13

DAYS

INVENTORY TURNOVER

2,96

TIMES

2,57

TIMES

2,48

TIMES

ACCOUNTS PAYABLE PERIOD

65,56

DAYS

54,89

DAYS

64,77

DAYS

RETURN ON ASSETS

1,25

TIMES

1,10

TIMES

1,59

TIMES

SALES TURNOVER ON NET EQUITY

2,79

TIMES

2,90

TIMES

2,38

TIMES

NET WORTH TIE-UP

,33

 

,42

 

,33

 

INDEBTEDNESS

1,23

 

1,64

 

,49

 

EQUITY RATIO

44,79

%

37,84

%

67,03

%

WORKING CAPITAL RATIO

25,24

%

23,48

%

125,40

%

GENERAL SOLVENCY

1,81

 

1,61

 

3,03

 

RETURN ON NET EQUITY

32,47

%

26,19

%

30,78

%

RETURN ON SALES (PROFIT MARGIN)

11,65

%

9,04

%

12,95

%

GROSS PROFIT MARGIN

73,84

%

74,51

%

74,02

%

OPERATIONAL RESULT

17,15

%

14,99

%

19,45

%

SALES TURNOVER ON LIABILITIES

4,22

TIMES

2,77

TIMES

6,05

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

 

EXCHANGE RATE:

 

US$ 1,00 = R$ 2,37

US$ 1,00 = R$ 2,04

US$ 1,00 = R$ 1,87

US$ 1,00 = R$ 1,66

 

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS HIGH BUT IT IS NOTED NORMAL CURRENT RATIO AND POSITIVE WORKING CAPITAL AMOUNT. IN ADDITION IT SHOWS GROWING SALES AND PROFITABILITY.

 

 

REAL ESTATE:

 

NOT AVAILABLE

 

 

VEHICLES:

 

NOT AVAILABLE

 

 

MACHINES:

 

NOT AVAILABLE

 

 

INSURANCE

 

THE SUBJECT IS SAID TO HOLD INSURANCE POLICIES BUT DETAILS WERE NOT DISCLOSED.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO DO BRASIL S/A

0287

 

BANCO BRADESCO S/A

0227

 

HSBC BANK BRASIL S/A

0614

 

BANCO UNIBANCO S/A

0272

 

BANCO RURAL S/A

0038

 

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

 

SUBJECT IS ENGAGED IN THE MANUFACTURING OF MANUFACTURE OF PHARMACEUTICALS

 

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

 

NOT AVAILABLE

 

EXPORTS TO:

 

NOT AVAILABLE

 

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

 

ALTO MIUDEZAS COMERCIAL LTDA

 

 

DROGUISTAS POTIGUARES REUNIDOS LTDA

 

 

INTERMED FARMACÊUYICA LTDA

 

 

ITA REPRESENTAÇÕES DE PRODS FARMACÊUTICOS LTDA

 

 

JORGE BATISTA & CIA LTDA

 

 

REYDROGAS COMERCIAL LTDA

 

 

 

 

STAFF:

 

THE COMPANY HAS: 817 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS AN OLD-ESTABLISHED COMPANY, OPERATING SINCE 1946. SO FAR IT HAS A CLEAR TRADE HISTORY AND NO PAYMENT PROBLEMS ARE NOTED.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

MOST OF THE SUPPLIERS, WHICH PROVIDED INFORMATION REPORTED PROMPT PAYMENTS, IT MAY BE NOTED SUBJECT HAS A VERY GOOD TRADE BEHAVIOR.

 

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

 

AGRO QUIMICA MARINGA LTDA

 

 

FAPATI IND E COM DE MATERIAL PLASTICO LTDA

 

 

MACRON INDUSTRIA GRÁFICA LTDA

 

 

SALDEQUIMICA COMERCIAL LTDA

 

 

WHEATON DO BRASIL INDUSTRIA E COMERCIO LTDA

 

 

 

 

PAYMENT HISTORY:

 

 

7 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 103.460,00

 

AMOUNT OF INVOICES PAID: 21

TOTAL OF PROMPT PAYMENTS: 100%

HIGHEST INVOICE: R$ 42.395,00

HIGHEST CREDIT: R$ 42.395,00

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS A GOOD FINANCIAL STANDING, A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOUR.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

A CREDIT LIMIT OF USD 1.000.000,00 MAY BE CONSIDERED.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.16

UK Pound

1

Rs. 103.44

Euro

1

Rs. 85.26

 

 

INFORMATION DETAILS

 

Report Prepared by :

DPT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.